National Institute Of Dental And Craniofacial Research (nidcr)

This study tested the safety of an oral drug called tofacitinib in 23 adults with mild-to-moderate Sjogren's syndrome, an autoimmune disease. Participants took the drug or a placebo daily for 168 days and were monitored for side effects. The goal was to see if tofacitinib is safe…